Tom E.

Tom E. has a diverse work experience in the biopharmaceutical industry. Starting in 2007, they had co-op positions at New England Controls, Genzyme (a Sanofi company), and Merrimack, where they gained exposure to chemical engineering. In 2010, they worked as a Technical Operations Engineer at Merck. From 2010 to 2012, they worked at Omnia Biologics as a Manufacturing Associate, supporting the contract manufacture of Phase 1 clinical trial material for an HIV-1 vaccine candidate.

In 2012, Tom joined MilliporeSigma, where they held various roles over the years. Tom began as an Applications Engineer in the MSAT department, providing support for bioprocess purification technologies. Tom then progressed to become a Biomanufacturing Engineer, specializing in chromatography technologies. In 2020, they were promoted to Sr. Biomanufacturing Engineer in MSAT, responsible for optimizing and scaling chromatography processes for biomolecule purification. Finally, from 2021 to 2023, they served as a Manager in the MSAT Purification Process Engineering team, leading a customer-facing group of process engineers.

In 2023, Tom joined Voyager Therapeutics, Inc. as a Sr. Engineer II in the Downstream Process Development department.

Tom E. obtained a Bachelor of Science degree in Chemical Engineering from Northeastern University. No specific start or end year for this education is mentioned.